Parkinson’s: Newly Approved Drug Gives Advanced-Stage Patients Longer Periods of Relief
The FDA’s recent approval of AbbVie’s new combination therapy provides patients with longer-lasting control of movements. As described recently in Biopharmadive, Parkinson’s disease is characterized by uncontrolled muscle movements or…